“Studying the role of focal adhesion kinase (FAK) and some of its effectors in patients with acute myeloid leukemia

Abstract

Focal adhesion kinase (FAK), human myofibrillogenesis regulator-1 (MR-1), ephrin receptor type A4 (EphA4), proto-oncogene tyrosine kinase Src (Src) and protein kinase C (PKC) are important markers in proliferation, survival, and migration in some cancers. However, the significance of each is still unclear in different malignancies, including Acute Myeloid Leukemia (AML). Therefore, this study was conducted to investigate their serum levels in Egyptian adult de novo AML patients (n=70) against healthy volunteers (n=20). We managed to study the correlation between each pair and to investigate their association with diagnosis, prognosis and survival. Serum levels were analyzed using enzyme-linked immunosorbent assay (ELISA). We found that FAK, MR-1, Src and PKC serum levels were significantly higher in AML patients compared to control (p>0.0001) and this was associated with significantly lower EphA4 level (p>0.0001). Interestingly, we also observed a significant negative correlation of FAK (p= 0.027), MR-1 (p= 0.003), Src (p= 0.038) and PKC (p= 0.03) with patients’ overall survival (OS) while there was a positive significant correlation between EphA4 and OS (p= 0.007). In conclusion, this study suggests that FAK, MR-1, EphA4, Src and PKC may be used as early diagnostic and prognostic markers with high sensitivity and specificity in AML patients and thus may be incorporated into the patients’ early diagnostic and